CANCER:

Mast Cell Leukemia

TMB-L TMB-L	Mast Cell Leukemia Mast Cell Leukemia	T-lymphocyte cell therapy Sensitive: C3 – Early Trials
LDH-L LDH-L	Mast Cell Leukemia Mast Cell Leukemia	T-lymphocyte cell therapy Sensitive: C3 – Early Trials
KIT D816V KIT D816V	Mast Cell Leukemia Mast Cell Leukemia	abemaciclib Sensitive: D – Preclinical
KIT D816V KIT D816V	Mast Cell Leukemia Mast Cell Leukemia	palbociclib Sensitive: D – Preclinical
KIT D816V KIT D816V	Mast Cell Leukemia Mast Cell Leukemia	ribociclib Sensitive: D – Preclinical

Associations(5)